Ocular Presentation News Today

New Investing Ideas in Biotech (NASDAQ: AGLE) (NASDAQ: MRTX) (NASDAQ: SXTP) (NYSE American: AZTR) (NASDAQ: KPRX) (NASDAQ: RSLS) (OTCQB: GENFF)

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) shares traded down 7.5% during mid-day trading on Tuesday . The stock traded as low as $0.76 and last traded at $0.78. 726,464 shares changed hands during trading, a decline of 24% from the average session volume of 950,251 shares. The stock had previously closed at $0.84. Analyst […]

Encinitas, California--(Newsfile Corp. - June 6, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the closing of an underwritten public offering for gross

Encinitas, California--(Newsfile Corp. - June 2, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the pricing of an underwritten public offering for gross

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 91,400 shares, an increase of 13.4% from the April 15th total of 80,600 shares. Currently, 5.4% of the shares of the company are short […]

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) saw a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 80,600 shares, a decline of 15.0% from the March 31st total of 94,800 shares. Currently, 4.7% of the shares of the company are short sold. Based on […]

Encinitas, California--(Newsfile Corp. - April 27, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) presented preliminary results from an ongoing clinical trial showing its investigational drug, KIO-301,

In a second presentation, Kiora shared additional positive results for its KIO-100 platform in the treatment of autoimmune uveitis. Encinitas, California--(Newsfile Corp. - April 26, 2023) - Kiora Pharmaceuticals

Encinitas, California--(Newsfile Corp. - April 21, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Mark Pennesi, M.D., Ph.D., the Kenneth C. Swan Endowed Professor in Ophthalmology and Molecular

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) dropped 2.4% on Monday . The stock traded as low as $3.93 and last traded at $4.05. Approximately 66,594 shares traded hands during trading, a decline of 95% from the average daily volume of 1,300,305 shares. The stock had previously closed at $4.15. Wall Street Analyst Weigh In […]